Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Fto Plays an Oncogenic Role in Acute Myeloid Leukemia As a N 6 -Methyladenosine RNA Demethylase

Blood (2016) 128 (22): 2706.

https://doi.org/10.1182/blood.V128.22.2706.2706

Published: 2016

Journal Articles

TET1 Regulates DNA Replication through Targeting of Minichromosome Maintenance Genes

Blood (2016) 128 (22): 2687.

https://doi.org/10.1182/blood.V128.22.2687.2687

Published: 2016

Journal Articles

Heterozygous RTEL1 variants in Patients with Bone Marrow Failure Associate with Telomere Dysfunction in the Absence of Telomere Shortening

Fernanda Gutierrez-Rodrigues, MSc, PharmD, Sachiko Kajigaya, PhD, Xingmin Feng, PhD, Maria del Pilar Fernandez Ibanez, MS, Marie J. Desierto, BS, Keyvan Keyvanfar, BS, Zejuan Li, MD PhD, Soma Das, PhD, Rodrigo T. Calado, MD PhD, Danielle M. Townsley, MD, Neal S. Young

Blood (2016) 128 (22): 1044.

https://doi.org/10.1182/blood.V128.22.1044.1044

Published: 2016

Journal Articles

Overexpression and Knockout of Mir-126 Both Promote Leukemogenesis through Targeting Distinct Gene Signaling

Blood (2015) 126 (23): 3667.

https://doi.org/10.1182/blood.V126.23.3667.3667

Published: 2015

Journal Articles

Uncover TET1 Targets in MLL -Rearranged Leukemia

Hengyou Weng, PhD, Huilin Huang, PhD, He Huang, PhD, Okwang Kwon, Ping Chen, Xi Jiang, PhD, Chao Hu, Hao Huang, PhD, Yungui Wang, PhD, Xi Qin, Stephen Arnovitz, Shenglai Li, Jennifer Strong, Rui Su, PhD, Mary Beth Neilly, Zejuan Li, MD PhD, Yingming Zhao, Jianjun Chen, PhD

Blood (2015) 126 (23): 3632.

https://doi.org/10.1182/blood.V126.23.3632.3632

Published: 2015

Journal Articles

Identification of Genetic Hereditary Predisposition to Hematologic Malignancies By Clinical Next-Generation Sequencing

Amy E Knight Johnson, MS, Lucia Guidugli, PhD, Kelly Arndt, BA, Gorka Alkorta-Aranburu, PhD, Viswateja Nelakuditi, MS, Jane E. Churpek, MD, Lucy A Godley, MD PhD, Daniela del Gaudio, PhD, Soma Das, PhD, Zejuan Li, MD PhD

Blood (2015) 126 (23): 3854.

https://doi.org/10.1182/blood.V126.23.3854.3854

Published: 2015

Journal Articles

Targeted Treatment of FLT3 -Overexpressing Acute Myeloid Leukemia with MiR-150 Nanoparticles Guided By Conjugated FLT3 Ligand Peptides

Blood (2015) 126 (23): 3784.

https://doi.org/10.1182/blood.V126.23.3784.3784

Published: 2015

Journal Articles

Identification of TET1⊣miR-22⊣CREB-MYC Signaling Reveals Potent Tumor-Suppressor Role of Mir-22 in Acute Myeloid Leukemia

Blood (2014) 124 (21): 886.

https://doi.org/10.1182/blood.V124.21.886.886

Published: 2014

Journal Articles

Polycomb Group Member Rybp Is a Functional Tumor Suppressor Repressed By Mir-9 in MLL-Rearranged AML

Colles Price, Ping Chen, Shenglai Li, Zejuan Li, MD PhD, Yuanyuan Li, Xi Jiang, PhD, Hao Huang, PhD, Hengyou Weng, PhD, Bryan Ulrich, Stephen Arnovitz, Mary Beth Neilly, Jianjun Chen, PhD

Blood (2014) 124 (21): 871.

https://doi.org/10.1182/blood.V124.21.871.871

Published: 2014

Journal Articles

Identification of MLL-Fusion/Myc⊣miR-26a/Mir-29a⊣Tet1 Signaling Circuit in MLL -Rearranged Leukemia

Hao Huang, PhD, Xi Jiang, PhD, Jinhua Wang, Yuanyuan Li, Ping Chen, Stephen Arnovitz, Shenglai Li, Yungui Wang, Hengyou Weng, PhD, Mary Elizabeth Neilly, Zejuan Li, MD PhD, Jianjun Chen, PhD

Blood (2014) 124 (21): 1011.

https://doi.org/10.1182/blood.V124.21.1011.1011

Published: 2014

Journal Articles

AML Cells Utilize TNF-Driven JNK Signaling As a Critical NF-κB-Independent Survival Signal

Andrew Volk, Jing Li, PhD, Junping Xin, PhD, Dewen You, PhD, Jun Zhang, PhD, Peter Breslin, PhD, Zejuan Li, MD, PhD, Wei Wei, Rachel Schmidt, Xinyu Li, MD, Zhou Zhang, PhD, Paul C Kuo, MD, Sucha Nand, MD, Jianke Zhang, PhD, Jianjun Chen, PhD, Jiwang Zhang, MD, PhD

Blood (2013) 122 (21): 2890.

https://doi.org/10.1182/blood.V122.21.2890.2890

Published: 2013

Journal Articles

MLL-Rearranged Acute Myeloid Leukemias Drive Expression Of Mir-9, a Critical Oncogene In Leukemogenesis

Colles Price, Ping Chen, MD, Zejuan Li, MD, PhD, Yuanyuan Li, Anissa Wiley, Chunjiang He, PhD, Rejani B. Kunjamma, Hao Huang, PhD, Xi Jiang, PhD, Stephen Arnovitz, Mary Beth Neilly, Janet D. Rowley, MD, Jianjun Chen, PhD

Blood (2013) 122 (21): 3740.

https://doi.org/10.1182/blood.V122.21.3740.3740

Published: 2013

Journal Articles

The HOXA/PBX3 Pathway Is an Attractive Therapeutic Target in MLL -Rearranged Acute Leukemia

Blood (2012) 120 (21): 3522.

https://doi.org/10.1182/blood.V120.21.3522.3522

Published: 2012

Journal Articles

Blockade of Mir-150 Maturation by MLL -Fusion/MYC/Lin-28 Is Required for MLL -Associated Leukemia

Blood (2012) 120 (21): 3499.

https://doi.org/10.1182/blood.V120.21.3499.3499

Published: 2012

Journal Articles

MLL-Associated Leukemias Drive Expression of MiR-9, Required for Tumorigenesis

Blood (2012) 120 (21): 525.

https://doi.org/10.1182/blood.V120.21.525.525

Published: 2012

Journal Articles

Activation of a Mir-181-Targeting HOXA-PBX3 Homeobox Gene Signature Is Associated with Adverse Prognosis of Cytogenetically Abnormal Acute Myeloid Leukemia

Blood (2011) 118 (21): 236.

https://doi.org/10.1182/blood.V118.21.236.236

Published: 2011

Journal Articles

MLL-Rearrangements Result in Upregulation of Mir-9 and Subsequent Inhibition of the Tumor Suppressor TGFBI

Colles O. Price, Ping Chen, MD, Zejuan Li, MD, PhD, Yuanyuan Li, Anissa Wiley, Chunjiang He, PhD, Hao Huang, PhD, Xi Jiang, PhD, Stephen Arnovitz, Mary Beth Neilly, Janet D. Rowley, MD, Jianjun Chen, PhD

Blood (2011) 118 (21): 2453.

https://doi.org/10.1182/blood.V118.21.2453.2453

Published: 2011

Journal Articles

Repression of Mir-495, a Microrna Associated with Favorable Outcome of Acute Myeloid Leukemia Patients, Is Required for the MLL -Associated Leukemogenesis,

Xi Jiang, PhD, Hao Huang, PhD, Zejuan Li, MD, PhD, Yuanyuan Li, Ping Chen, MD, Chunjiang He, PhD, Stephen Arnovitz, Mary Beth Neilly, Janet D. Rowley, MD, Jianjun Chen, PhD

Blood (2011) 118 (21): 3462.

https://doi.org/10.1182/blood.V118.21.3462.3462

Published: 2011

Journal Articles

The AML Prognostic Marker, AF1q, Is Directly Regulated by MiR-29b.

Yin Xiong, PhD, Zejuan Li, MD, PhD, Aik Choon Tan, Judson Bemis, Xiuyan Xie, Kevin D. Bunting, PhD, Jianjun Chen, Lynne Bemis, Ph.D, William Tse, M.D.

Blood (2009) 114 (22): 2603.

https://doi.org/10.1182/blood.V114.22.2603.2603

Published: 2009

Journal Articles

Identification of Genes Deregulated in Both Human and Murine MLLRearrangement Leukemias.

Zejuan Li, MD, PhD, Roger T. Luo, Shuangli Mi, Miao Sun, Ping Chen, Mary Beth Neilly, Yanming Zhang, Janet D. Rowley, Michael J. Thirman, Jianjun Chen

Blood (2008) 112 (11): 3359.

https://doi.org/10.1182/blood.V112.11.3359.3359

Published: 2008

NARROW

Fto Plays an Oncogenic Role in Acute Myeloid Leukemia As a N 6 -Methyladenosine RNA Demethylase

TET1 Regulates DNA Replication through Targeting of Minichromosome Maintenance Genes

Heterozygous RTEL1 variants in Patients with Bone Marrow Failure Associate with Telomere Dysfunction in the Absence of Telomere Shortening

Overexpression and Knockout of Mir-126 Both Promote Leukemogenesis through Targeting Distinct Gene Signaling

Uncover TET1 Targets in MLL -Rearranged Leukemia

Identification of Genetic Hereditary Predisposition to Hematologic Malignancies By Clinical Next-Generation Sequencing

Targeted Treatment of FLT3 -Overexpressing Acute Myeloid Leukemia with MiR-150 Nanoparticles Guided By Conjugated FLT3 Ligand Peptides

Identification of TET1⊣miR-22⊣CREB-MYC Signaling Reveals Potent Tumor-Suppressor Role of Mir-22 in Acute Myeloid Leukemia

Polycomb Group Member Rybp Is a Functional Tumor Suppressor Repressed By Mir-9 in MLL-Rearranged AML

Identification of MLL-Fusion/Myc⊣miR-26a/Mir-29a⊣Tet1 Signaling Circuit in MLL -Rearranged Leukemia

AML Cells Utilize TNF-Driven JNK Signaling As a Critical NF-κB-Independent Survival Signal

MLL-Rearranged Acute Myeloid Leukemias Drive Expression Of Mir-9, a Critical Oncogene In Leukemogenesis

The HOXA/PBX3 Pathway Is an Attractive Therapeutic Target in MLL -Rearranged Acute Leukemia

Blockade of Mir-150 Maturation by MLL -Fusion/MYC/Lin-28 Is Required for MLL -Associated Leukemia

MLL-Associated Leukemias Drive Expression of MiR-9, Required for Tumorigenesis

Activation of a Mir-181-Targeting HOXA-PBX3 Homeobox Gene Signature Is Associated with Adverse Prognosis of Cytogenetically Abnormal Acute Myeloid Leukemia

MLL-Rearrangements Result in Upregulation of Mir-9 and Subsequent Inhibition of the Tumor Suppressor TGFBI

Repression of Mir-495, a Microrna Associated with Favorable Outcome of Acute Myeloid Leukemia Patients, Is Required for the MLL -Associated Leukemogenesis,

The AML Prognostic Marker, AF1q, Is Directly Regulated by MiR-29b.

Identification of Genes Deregulated in Both Human and Murine MLLRearrangement Leukemias.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only